KNR Construct
Sharekhan
Broker Research reports: Buy reports
for all stocks
- This broker has downgraded this stock from it's previous report. (eg. - Buy->Hold)
- Broker has maintained previous recommendation but reduced share price target.
- This broker has upgraded this stock from it's previous report.(eg. - Sell->Hold)
- Broker has maintained previous recommendation but increased share price target.
RESEARCH REPORTS ALERTS
Load latest
Google or static link led you to an intermediate page.
- All Recent
- Upside
- Buy
- Sell
- Recent Upgrades
- Recent Downgrades
- IPO
- Sector Updates
- Most Recent
- Top Upside
Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.
| Summary | Date | Stock | Author | LTP | Target | Price at reco (Change since reco%) |
Upside(%) | Type | Report | Discuss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 30 May 2023 | KNR Constructions |
Sharekhan
|
204.08 | 301.00 | 249.65 (-18.25%) | Target met |
Buy
|
||||
| 30 May 2023 | Sun Pharmaceutical |
BOB Capital Markets Ltd.
|
1656.00 | 1130.00 | 959.60 (72.57%) | Target met |
Buy
|
||||
| 30 May 2023 | Mahindra & Mahindra |
BOB Capital Markets Ltd.
|
3592.10 | 1665.00 | 1328.45 (170.40%) | Target met |
Buy
|
||||
| 30 May 2023 | Gokaldas Exports |
ICICI Securities Limited
|
835.55 | 560.00 | 416.55 (100.59%) | Target met |
Buy
|
Sailing smoothly in turbulent tides
ICICI Securities Limited
Gokaldas Exports’ (GEXP) Q4FY23 consolidated EBITDA at Rs701mn, although down 8.5% YoY, was above our / consensus expectations. Revenue at Rs5.2bn was flat QoQ (down 11% YoY) due to soft demand scenario in the company’s end-market (US).
|
|||
| 30 May 2023 | Rolex Rings |
IDBI Capital
|
1379.30 | 2500.00 | 1919.50 (-28.14%) | Target met |
Buy
|
||||
| 30 May 2023 | NCC |
IDBI Capital
|
216.99 | 154.00 | 114.65 (89.26%) | Target met |
Buy
|
||||
| 30 May 2023 | Ahluwalia Contracts |
IDBI Capital
|
988.35 | 697.00 | 599.35 (64.90%) | Target met |
Buy
|
||||
| 30 May 2023 | Repco Home Finance |
IDBI Capital
|
376.50 | 300.00 | 256.80 (46.61%) | Target met |
Buy
|
||||
| 30 May 2023 | Aurobindo Pharma |
Axis Direct
|
1119.20 | 700.00 | 650.75 (71.99%) | Target met |
Buy
|
||||
| 30 May 2023 | Ahluwalia Contracts |
Axis Direct
|
988.35 | 650.00 | 599.35 (64.90%) | Target met |
Buy
|
||||
|
more
loading
|
|||||||||||
* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.